PharmaCyte Biotech/ US71715X2036 /
| 2021-08-09 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 7.0000USD | - | 27,350 Turnover: - |
-Bid Size: - | -Ask Size: - | 10.0000 | 6.5700 |
GlobeNewswire
2023-11-15
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte...
GlobeNewswire
2020-08-03
PharmaCyte Biotech Ready to Submit Investigational New Drug Application to FDA for Clinical Trial in...
GlobeNewswire
2020-06-29
PharmaCyte Biotech’s COVID-19 Test Offers “Pool Testing” Dr. Fauci and White House Coronavirus Task ...
GlobeNewswire
2020-04-20
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path t...
GlobeNewswire
2020-04-13
PharmaCyte Biotech to Offer COVID-19 Testing While Creating Revenue Stream for Pancreatic Cancer Pro...
GlobeNewswire
2020-03-26
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic
Newsfile Corp
2020-02-11
Will PharmaCyte Biotech's Cell-in-a-Box(R) Technology Be The Game Changer To Effectively Treating Pa...
Newsfile Corp
2020-02-06
PharmaCyte Biotech Exploits Potential Of Its Cell-in-a-Box(R) Technology; Targets Billion Dollar Can...
GlobeNewswire
2020-02-04
PharmaCyte Biotech Will Have All the Protection It Needs for Pancreatic Cancer Treatment Upon Market...
GlobeNewswire
2020-01-27
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IN...
GlobeNewswire
2020-01-14
PharmaCyte Biotech Addressing Unmet Need in Patients with LAPC as Pancreatic Cancer 5-Year Survival ...
GlobeNewswire
2019-12-11
PharmaCyte Biotech Finalizes Pancreatic Cancer Treatment for U.S. FDA Approval to Begin Clinical Tri...
GlobeNewswire
2019-11-12
PharmaCyte Biotech’s “Release Testing” Last Critical Event Before Submission of Investigational New ...
GlobeNewswire
2019-10-28
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology...
GlobeNewswire
2019-10-16
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product
GlobeNewswire
2019-09-23
PharmaCyte Biotech's Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run
GlobeNewswire
2019-06-27
Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Ma...
GlobeNewswire
2019-01-23
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancrea...
GlobeNewswire
2018-09-21
Global Pancreatic Cancer Therapy Market Analysis and Forecasts 2017-2025 - Increase in Number of The...
GlobeNewswire
2018-06-06
PharmaCyte’s Clinical Trial in Pancreatic Cancer Serves as Proving Ground for Its One of a Kind Cell...
